What does mtor do
Sci Immunol. J Clin Invest. Nat Commun. Cancer Sci. An intronic polymorphism in GRP78 improves chemotherapeutic prediction in non-small cell lung cancer. Free Radic Biol Med. Transcriptome analysis reveals an important candidate gene involved in both nodal metastasis and prognosis in lung adenocarcinoma. Cell Biosci. J Thorac Oncol. Clin Cancer Res. Respir Res. The cancer exosomes: clinical implications, applications and challenges.
Int J Cancer. Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockade. Co-occurring genomic alterations and association with progression-free survival in BRAFVmutated nonmelanoma tumors. J Natl Cancer Inst. Therapy-induced tumour secretomes promote resistance and tumour progression. The single-cell sequencing: new developments and medical applications. Cancer Cell Int.
Microsatellite instability: a review of what the oncologist should know. J Cell Biol. Cell Death Dis. J Clin Endocrinol Metab. Decreased incidence of Kaposi sarcoma after kidney transplant in Italy and role of mTOR-inhibitors: — Transcriptional regulation in model organisms: recent progress and clinical implications.
Open Biol. Genomic correlates of response to everolimus in aggressive radioiodine-refractory thyroid cancer: a phase II study. Targeting mTOR dependency in pancreatic cancer. J Clin Oncol. Mol Cancer Ther. Two novel TSC2 mutations in renal epithelioid angiomyolipoma sensitive to everolimus.
Cancer Biol Ther. Biallelic TSC2 mutations in a patient with chromophobe renal cell carcinoma showing extraordinary response to temsirolimus. J Natl Compr Cancer Netw. Article Google Scholar. Jacob LA, Shafi G. Indian J Cancer. GWAS in cancer: progress and challenges.
Mol Genet Genom. Gynecol Oncol. RNA-based pharmacotherapy for tumors: from bench to clinic and back. Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial. Lancet Oncol. Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma: a multicenter phase II trial.
Ann Oncol. Download references. You can also search for this author in PubMed Google Scholar. Correspondence to Hongmei Li or Xiao Zhu. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material.
If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
Reprints and Permissions. Zou, Z. Cell Biosci 10, 31 Download citation. Received : 18 December Accepted : 26 February Published : 10 March Anyone you share the following link with will be able to read this content:.
Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative.
Skip to main content. Search all BMC articles Search. Download PDF. Abstract Mammalian target of rapamycin mTOR regulates cell proliferation, autophagy, and apoptosis by participating in multiple signaling pathways in the body.
The relationship between mTOR signaling pathway and tumors Tumor growth and proliferation Under normal circumstances, mTOR is a major regulator of cell growth and division. Full size image. Conclusion and prospect The mTOR signaling pathway is closely related to tumors, and it is closely related to its cell growth, metabolism, apoptosis and autophagy [ 47 , 81 ]. Availability of data and materials Not applicable. References 1.
Article PubMed Google Scholar 2. Article PubMed Google Scholar 8. PubMed Google Scholar PubMed Article Google Scholar Article Google Scholar View author publications. Ethics declarations Ethics approval and consent to participate Not applicable.
Consent for publication All authors consent for publication. Competing interests The authors declare that they have no competing interests. Additional information Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article. Cite this article Zou, Z. Copy to clipboard. Contact us Submission enquiries: Access here and click Contact Us General enquiries: info biomedcentral. Lokireddy, S. Myostatin promotes the wasting of human myoblast cultures through promoting ubiquitin-proteasome pathway-mediated loss of sarcomeric proteins. Cell Physiol. Ma, K. Characterization of 5'-regulatory region of human myostatin gene: regulation by dexamethasone in vitro.
PubMed Abstract Google Scholar. Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Ma, X. Molecular mechanisms of mTOR-mediated translational control. Manning, B. Markofski, M. Effect of age on basal muscle protein synthesis and mTORC1 signaling in a large cohort of young and older men and women. Matsumoto, A. McCarthy, J. Anabolic and catabolic pathways regulating skeletal muscle mass.
Care 13, — McFarlane, C. Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism. McPherron, A. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature , 83— Meijsing, S. DNA binding site sequence directs glucocorticoid receptor structure and activity.
Menconi, M. Role of glucocorticoids in the molecular regulation of muscle wasting. Care Med. Menon, S. Munck, A. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Musaro, A. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. O'Neil, T. The role of phosphoinositide 3-kinase and phosphatidic acid in the regulation of mammalian target of rapamycin following eccentric contractions.
Pallafacchina, G. A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Parkington, J. PubMed Abstract. Passtoors, W. Gene expression analysis of mTOR pathway: association with human longevity. Aging Cell 12, 24— Pelosi, L. Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines. Powers, R. Extension of chronological life span in yeast by decreased TOR pathway signaling.
Rabinovsky, E. Targeted expression of IGF-1 transgene to skeletal muscle accelerates muscle and motor neuron regeneration. Ramos, F. Risson, V. Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy. Robida-Stubbs, S. Rommel, C. Sakuma, K.
The intriguing regulators of muscle mass in sarcopenia and muscular dystrophy. Aging Neurosci. Sancak, Y. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Sandri, M. Biogerontology 14, — Sarbassov, D. Growing roles for the mTOR pathway. Sartori, R.
Trends Endocrinol. Smad2 and 3 transcription factors control muscle mass in adulthood. Saxton, R. Schakman, O. Mechanisms of glucocorticoid-induced myopathy. Schiaffino, S.
Sharples, A. The role of insulin-like-growth factor binding protein 2 IGFBP2 and phosphatase and tensin homologue PTEN in the regulation of myoblast differentiation and hypertrophy.
Growth Horm. IGF Res. Shimizu, N. Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle. Song, Z. Resistance exercise initiates mechanistic target of rapamycin mTOR translocation and protein complex co-localisation in human skeletal muscle. Spangenburg, E. A functional insulin-like growth factor receptor is not necessary for load-induced skeletal muscle hypertrophy.
Sun, Y. Mammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesis. Timmerman, K. Pharmacological vasodilation improves insulin-stimulated muscle protein anabolism but not glucose utilization in older adults. Diabetes 59, — Trendelenburg, A. Um, S. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Vandenburgh, H. Insulin and IGF-I induce pronounced hypertrophy of skeletal myofibers in tissue culture. Walston, J.
Sarcopenia in older adults. Wang, X. Signaling functions of phosphatidic acid. Trends Neurosci. Epub Dec 4. Adv Biol Regul. Epub Jan 4. Nat Med. Epub Mar JAMA Neurol. GluLys and evidence for paternal gonadal mosaicism. Am J Med Genet A. Epub Oct Germline and somatic mutations in the MTOR gene in focal cortical dysplasia and epilepsy. Neurol Genet. Ann Neurol. Epub Jul 3.
0コメント